Original news and analysis on international IP policy
A Wells Fargo bank manager in California worked with two colleagues to conduct a scam targeting trademark holders and launder the proceeds, the United States Department of Justice said today.
DURBAN, South Africa - The lessons derived from the history of AIDS treatment have become a rallying call for civil society organisations globally. Not being able to afford AIDS medicines should not be repeated for people with other diseases, including HIV co-infections, treatment activists told world leaders here.
The United Kingdom-based Anti-Counterfeiting Group (ACG) industry group launched a "manifesto" earlier this month, calling on the government to establish a more effective and comprehensive response to intellectual property crime.
The European Union Intellectual Property Office (EUIPO) and the European Commission Trade Directorate recently launched a new intellectual property enforcement tool that aims to pool together all data relating to IP rights infringement experienced by EU companies into one database to help build prevention strategies. This is one of many new EU initiatives to counter growing IPR infringement and counterfeits.
The International Confederation of Societies of Authors and Composers (CISAC), the world's leading network of authors’ societies, has published a book looking back at its 90 years in existence. The CISAC Story - 90 Years in the Service of Authors and Creators Worldwide, was distributed in three languages at the Confederation’s General Assembly last month in Paris.
NAIROBI, Kenya (IP-Watch) – The United Nations Conference on Trade and Development (UNCTAD) 14th Session opened here yesterday, with leaders calling for deeper and broader cooperation between trade and development.
Top negotiators of the European Union and United States today underlined after the 14th round of negotiations for the Transatlantic Trade and Investment Partnership (TTIP) that they are still on track for finalising the deal during the outgoing Obama administration. At the same time, they acknowledged that after three years of negotiations some chapters have never been discussed.
Worldwide sales for orphan drugs are forecast to reach $178 billion by 2020, according to a recent industry report. Moreover, the orphan drug market is expected to grow almost 12 percent per year, a level the broader pharmaceutical market “could only dream about” with its expected annual growth of 5.9 percent, according to Lisa Urquhart, editor of EvaluatePharma Vantage.
Gilead is the US company whose use of patents to charge $1000 per pill for a hepatitis C medicine in the United States helped make high drug prices a developed country household issue and fodder for elected officials seeking change. Now the company has come under further fire after being found to have moved some US$10 billion overseas to avoid US taxes - even after having received US taxpayer support for its activities - which it orchestrated by moving its patent rights overseas. A new report detailing the company's tax dodge includes a proposal for a way to clamp down on this type of patent activity.
A bill introduced in Kenya’s parliament intended to streamline, govern and regulate the country’s information and communications technology (ICT) sector has been met with opposition from different quarters over fears that it could put ICT technicians out of practice and stifle the country’s innovation capacity if passed into law.
BARCELONA, Spain -- The Huawei v ZTE Case C - 170/13, 21 July 2015 prescribed some guidelines for fair, reasonable and non-discriminatory (FRAND) licensing negotiations, for both standard-essential patent holders and users. A recent private-sector panel addressed European FRAND case law and the latest information and communications technology industry policy opinions, in particular concerning royalty assessment rate (end-user or technology), royalty stacking, patent pool approach and injunctions.
BARCELONA, Spain -- A recent industry conference panel here covered topics of changing intellectual property scenarios perceived from different angles, in particular from operating companies which manufacture products or services and patent assertion entities (PAEs).